Capvizr

Ro Raises $500 million Series D

Company profile · Healthcare & Life Sciences · Updated March 1, 2021

Ro has raised $500M in Series D funding led by General Catalyst, with participation from General Catalyst, FirstMark, TQ Ventures. Wisp Acquires TBD Health, Launching Enterprise and Hybrid Care Offerings

Series D$500 millionTotal tracked $500 millionNew York, NY

What it does

Wisp Acquires TBD Health, Launching Enterprise and Hybrid Care Offerings This addresses can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?.

Traction

Wisp Acquires TBD Health, Launching Enterprise and Hybrid Care Offerings The company is using its latest financing to scale, with the Series D round serving as the clearest current traction signal in the source bundle.

Trend impact

Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? As adoption in Healthcare & Life Sciences expands, focused products from Ro can pressure incumbents or broader platforms that do not address the same problem directly.

Funding history

  • March 1, 2021 · Series D · $500 million · General Catalyst

Products & services

  • On National Viagra Day, Women Finally Claim Their Turn capability
  • GlobeNewswire. On National Viagra Day, Women Finally Claim Their Turn capability
  • GlobeNewswire capability
  • GlobeNewswire Wisp Acquires TBD Health, Launching Enterprise and Hybrid capability
  • Care Offerings - Business Wire. Wisp Acquires TBD Health, Launching capability
Open Ro in the interactive Capvizr dashboard →